麝香通心滴丸联合西药治疗缺血性心肌病并发慢性心力衰竭气虚血瘀证临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R542.2;R541.6

基金项目:


Clinical Study on Shexiang Tongxin Dripping Pills Combined with Western Medicine for Ischemic Cardiomyopathy Complicated with Chronic Heart Failure with Qi Deficiency and Blood Stasis Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察麝香通心滴丸联合西药治疗缺血性心肌病(ICM) 并发慢性心力衰竭(CHF) 气虚血 瘀证的临床疗效。方法:选取100 例ICM 并发CHF 气虚血瘀证患者,按随机数字表法分为治疗组与对照组各 50 例。对照组给予西药治疗,治疗组在对照组基础上给予麝香通心滴丸治疗,2 组均治疗4 周。比较2 组临床 疗效,治疗前后中医证候积分、心功能指标[平均室壁应力(MWS)、左室心肌质量指数(LVMI)、血清N 末 端B 型利钠肽原(NT-proBNP)] 与血清晚期糖基化终末产物受体(RAGE)、核转录因子(NF) -κB 及S100 钙结合蛋白A8/A9 复合物(S100A8/A9) 水平。结果:治疗后,治疗组临床疗效总有效率98.00%,高于对照 组86.00%(P<0.05)。治疗后,2 组中医证候积分均较治疗前降低(P<0.05),治疗组中医证候积分低于对照 组(P<0.05)。治疗后,2 组MWS、LVMI 及血清NT-proBNP 水平均较治疗前降低(P<0.05), 治疗组 MWS、LVMI 及血清NT-proBNP 水平均低于对照组(P<0.05)。治疗后, 2 组血清RAGE、NF-κB、 S100A8/A9 水平均较治疗前降低(P<0.05),治疗组血清RAGE、NF-κB、S100A8/A9 水平均低于对照组(P< 0.05)。结论:麝香通心滴丸联合西药治疗ICM 并发CHF 气虚血瘀证疗效确切,可减轻患者的临床症状,改善 其心功能,作用机制可能与下调血清NT-proBNP、RAGE、NF-κB、S100A8/A9 水平有关。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Shexiang Tongxin Dripping Pills combined with western medicine for ischemic cardiomyopathy (ICM) complicated with chronic heart failure (CHF) with qi deficiency and blood stasis syndrome. Methods:A total of 100 cases of patients who had ICM complicated with CHF of qi deficiency and blood stasis syndrome were selected and divided into the treatment group and the control group according to the random number table method,with 50 cases in each group. The control group was treated with western medicine,and the treatment group was additionally treated with Shexiang Tongxin Dripping Pills based on the treatment of the control group. Both groups were treated for 4 weeks. Clinical effects were compared between the two groups. Traditional Chinese medicine (TCM) syndrome scores, the heart function indexes [mean wall stress (MWS), left ventricular myocardial mass index (LVMI),serum N-terminal B-type natriuretic peptide (NT-proBNP)],and the levels of serum receptor for advanced glycation end products (RAGE),nuclear factor- κB (NF- κB),and S100 calcium-binding protein A8/A9 complex (S100A8/A9) before and after treatment were compared between the two groups. Results: After treatment, the total clinical effective rate was 98.00% in the treatment group, higher than that of 86.00% in the control group (P<0.05). After treatment, TCM syndrome scores in the two groups were decreased when compared with those before treatment (P<0.05), and the score in the treatment group was lower than that in the control group (P<0.05). After treatment,the levels of MWS,LVMI,and serum NT- proBNP in the two groups were decreased when compared with those before treatment (P<0.05), and the levels of MWS,LVMI,and serum NT-proBNP in the treatment group were lower than those in the control group (P<0.05). After treatment,the levels of RAGE,NF-κB,and S100A8/A9 in serum in the two groups were decreased when compared with those before treatment (P<0.05),and the levels of RAGE, NF-κB,and S100A8/A9 in serum in the treatment group were lower than those in the control group (P< 0.05). Conclusion:Shexiang Tongxin Dripping Pills combined with western medicine has a definite curative effect in treating ICM complicated with CHF of qi deficiency and blood stasis syndrome, and can relieve clinical symptoms of patients and improve their heart function. Its mechanism may be related to the downregulation of the levels of serum RAGE,NF-κB,and S100A8/A9.

    参考文献
    相似文献
    引证文献
引用本文

孙亮,徐永伟,胡珍.麝香通心滴丸联合西药治疗缺血性心肌病并发慢性心力衰竭气虚血瘀证临床研究[J].新中医,2023,55(6):22-26

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-03-28
  • 出版日期:
文章二维码